Targeting of α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia and the Use of Auditory Sensory Gating as a Translational Biomarker
about
Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disordersThe translational study of apathy-an ecological approachNeuropsychological Impairment and Its Association with Violence Risk in Japanese Forensic Psychiatric Patients: A Case-Control StudyThe Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of Schizophrenia.Discovery, synthesis, biological evaluation and structure-based optimization of novel piperidine derivatives as acetylcholine-binding protein ligands.Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic TargetsTrue alignment of preclinical and clinical research to enhance success in CNS drug development: a review of the current evidence.The development of novel polypharmacological agents targeting the multiple binding sites of nicotinic acetylcholine receptors.Improving Current Treatments for Schizophrenia.Molecular function of α7 nicotinic receptors as drug targets.Muscarinic receptor signaling contributes to atypical antipsychotic drug reversal of the phencyclidine-induced deficit in novel object recognition in rats.The Cholinergic Anti-Inflammatory Response and the Role of Macrophages in HIV-Induced Inflammation.Current Concepts and Treatments of Schizophrenia
P2860
Q26765419-5B900317-9117-422E-8E62-90D85C9BF65EQ26781597-BDA23A1E-272B-4FF6-989F-5286C43442F1Q35908405-CF35832F-5984-4AB9-A5C8-FC604B9700CDQ36088364-E0616B7E-6C20-4D6D-A02C-0504E7D9335BQ36213170-CF3A6D24-83F6-4DAA-B3EE-76EF4A32E0ECQ37310546-B00B3365-3E16-4978-8AA7-B431298C6FA1Q38826210-B214B73E-8887-43FD-9373-7D9769D6A233Q38934855-1506D2AF-11DF-400E-BBD3-B3F0280707DAQ38955513-B80C1A86-DD1C-4F49-B3D8-86E54E76C8BEQ47409603-7D30CEEF-BFBC-47E1-9AA0-5253AD18FAEDQ47925112-C5922737-08F1-46D2-B554-E556E127F9E0Q55334318-FE383AD0-E3DD-428E-AFAB-112E4E1647CDQ58693044-168962B6-096B-4734-90E2-CED8E86138F4
P2860
Targeting of α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia and the Use of Auditory Sensory Gating as a Translational Biomarker
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 June 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting of α7 Nicotinic Acet ...... g as a Translational Biomarker
@en
Targeting of α7 Nicotinic Acet ...... as a Translational Biomarker.
@nl
type
label
Targeting of α7 Nicotinic Acet ...... g as a Translational Biomarker
@en
Targeting of α7 Nicotinic Acet ...... as a Translational Biomarker.
@nl
prefLabel
Targeting of α7 Nicotinic Acet ...... g as a Translational Biomarker
@en
Targeting of α7 Nicotinic Acet ...... as a Translational Biomarker.
@nl
P2860
P921
P1476
Targeting of α7 Nicotinic Acet ...... g as a Translational Biomarker
@en
P2093
Kenji Hashimoto
P2860
P304
P356
10.2174/1381612821666150605111345
P50
P577
2015-06-05T00:00:00Z